AI-generated fake prescriptions fueling misuse of antibiotics and psychotropic drugs are becoming a growing concern in India, raising serious questions about patient safety and online medicine sales. Health experts and chemists warn that fak...
Tata-backed MedTherapy claims a CAR-T breakthrough, marking what could be a major shift in cancer treatment manufacturing. The company says it can now produce CAR-T therapy within just 24 hours, compared to the several weeks the process usual...
Tata Elxsi has launched ViTel, an AI-driven material intelligence solution for medical device manufacturers, co-developed with Viridium AI. The new platform, formally introduced today at DeviceTalks Boston 2026, aims to help MedTech companie...
.jpeg)
Moderna and Merck melanoma combo cuts spread risk by 59% in 5-year study. Personalized cancer vaccine with Keytruda shows strong survival gains and recurrence prevention.
India emerges as Novo Nordisk’s global launch engine, powering AI-led drug development, faster approvals, and stronger Wegovy data amid rising competition in obesity drugs.
India's e-pharmacy market is rapidly growing, with top apps like PharmEasy, Apollo 24/7, Tata 1mg, Netmeds, and SastaSundar competing to offer the fastest delivery, best discounts, and smartest AI-powered features
In an interaction with Thiruamuthan, Assistant Editor at India Pharma Outlook, Suneela Thatte, VP and Head – Healthcare R&D for India, Merck KGaA, shares India’s transition from a cost-driven support hub to a strategic R&D innovator. She highlights
.jpeg)
India's e-pharmacy market is rapidly evolving with top apps offering hyperlocal delivery, AI-powered chronic care, and subscription models, even as the sector awaits a long-overdue regulatory framework.
India is taking a major step toward the future of healthcare with the launch of the UMMID programme, a nationwide initiative focused on genomic medicine and precision healthcare. The UMMID programme aims to strengthen India’s ability to diagnose...
India arrived at the 79th World Health Assembly in Geneva not only as a participant but also as a model for the AI healthcare revolution.
, CDSCO.jpg)